Cargando…
Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitat...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250422/ https://www.ncbi.nlm.nih.gov/pubmed/32453743 http://dx.doi.org/10.1371/journal.pone.0233373 |
_version_ | 1783538760266285056 |
---|---|
author | Chen, Huei-Mei Resendes, Rachel Ghodssi, Azita Sookiasian, Danielle Tian, Michael Dollive, Serena Adamson-Small, Laura Avila, Nancy Tazearslan, Cagdas Thompson, John F. Ellsworth, Jeff L. Francone, Omar Seymour, Albert Wright, Jason B. |
author_facet | Chen, Huei-Mei Resendes, Rachel Ghodssi, Azita Sookiasian, Danielle Tian, Michael Dollive, Serena Adamson-Small, Laura Avila, Nancy Tazearslan, Cagdas Thompson, John F. Ellsworth, Jeff L. Francone, Omar Seymour, Albert Wright, Jason B. |
author_sort | Chen, Huei-Mei |
collection | PubMed |
description | Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitative molecular characterization of the edited sequence that overcome technical obstacles such as excess episomal vector genomes and lengthy homology arms. Here we describe a novel molecular methodology that utilizes quantitative next-generation sequencing to characterize AAV-mediated targeted insertion and detects the presence of unintended mutations. The methods described here quantify targeted insertion and query the entirety of the target locus for the presence of insertions, deletions, single nucleotide variants (SNVs) and integration of viral components such as inverted terminal repeats (ITR). Using a humanized liver murine model, we demonstrate that hematopoietic stem-cell derived AAVHSC15 mediates in vivo targeted gene integration into human chromosome 12 at the PAH (phenylalanine hydroxylase) locus at 6% frequency, with no sign of co-incident random mutations at or above a lower limit of detection of 0.5% and no ITR sequences at the integration sites. Furthermore, analysis of heterozygous variants across the targeted locus using the methods described shows a pattern of strand cross-over, supportive of an HR mechanism of gene integration with similar efficiencies across two different haplotypes. Rapid advances in the application of AAV-mediated nuclease-free target integration, or gene editing, as a new therapeutic modality requires precise understanding of the efficiency and the nature of the changes being introduced to the target genome at the molecular level. This work provides a framework to be applied to homologous recombination gene editing platforms for assessment of introduced and natural sequence variation across a target site. |
format | Online Article Text |
id | pubmed-7250422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72504222020-06-08 Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 Chen, Huei-Mei Resendes, Rachel Ghodssi, Azita Sookiasian, Danielle Tian, Michael Dollive, Serena Adamson-Small, Laura Avila, Nancy Tazearslan, Cagdas Thompson, John F. Ellsworth, Jeff L. Francone, Omar Seymour, Albert Wright, Jason B. PLoS One Research Article Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitative molecular characterization of the edited sequence that overcome technical obstacles such as excess episomal vector genomes and lengthy homology arms. Here we describe a novel molecular methodology that utilizes quantitative next-generation sequencing to characterize AAV-mediated targeted insertion and detects the presence of unintended mutations. The methods described here quantify targeted insertion and query the entirety of the target locus for the presence of insertions, deletions, single nucleotide variants (SNVs) and integration of viral components such as inverted terminal repeats (ITR). Using a humanized liver murine model, we demonstrate that hematopoietic stem-cell derived AAVHSC15 mediates in vivo targeted gene integration into human chromosome 12 at the PAH (phenylalanine hydroxylase) locus at 6% frequency, with no sign of co-incident random mutations at or above a lower limit of detection of 0.5% and no ITR sequences at the integration sites. Furthermore, analysis of heterozygous variants across the targeted locus using the methods described shows a pattern of strand cross-over, supportive of an HR mechanism of gene integration with similar efficiencies across two different haplotypes. Rapid advances in the application of AAV-mediated nuclease-free target integration, or gene editing, as a new therapeutic modality requires precise understanding of the efficiency and the nature of the changes being introduced to the target genome at the molecular level. This work provides a framework to be applied to homologous recombination gene editing platforms for assessment of introduced and natural sequence variation across a target site. Public Library of Science 2020-05-26 /pmc/articles/PMC7250422/ /pubmed/32453743 http://dx.doi.org/10.1371/journal.pone.0233373 Text en © 2020 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Chen, Huei-Mei Resendes, Rachel Ghodssi, Azita Sookiasian, Danielle Tian, Michael Dollive, Serena Adamson-Small, Laura Avila, Nancy Tazearslan, Cagdas Thompson, John F. Ellsworth, Jeff L. Francone, Omar Seymour, Albert Wright, Jason B. Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title | Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title_full | Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title_fullStr | Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title_full_unstemmed | Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title_short | Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 |
title_sort | molecular characterization of precise in vivo targeted gene integration in human cells using aavhsc15 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250422/ https://www.ncbi.nlm.nih.gov/pubmed/32453743 http://dx.doi.org/10.1371/journal.pone.0233373 |
work_keys_str_mv | AT chenhueimei molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT resendesrachel molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT ghodssiazita molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT sookiasiandanielle molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT tianmichael molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT dolliveserena molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT adamsonsmalllaura molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT avilanancy molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT tazearslancagdas molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT thompsonjohnf molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT ellsworthjeffl molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT franconeomar molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT seymouralbert molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 AT wrightjasonb molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15 |